plos PLoS Currents: Huntington Disease 2157-3999 Public Library of Science San Francisco, USA 10.1371/currents.hd.976177e0cbf724437ea11745c9231a57 Correction Correction: Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease PLOS Currents - 11 7 2017 ecurrents.hd.976177e0cbf724437ea11745c9231a57 2019 PLOS Currents, et al This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Correction

There is an error in the second author’s name. The correct name is Elizabeth A. Wang. The correct citation is Chen JY, Wang EA, Galvan L, Huynh M, Joshi P, Cepeda C, Levine MS. Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease. PLOS Currents Huntington Disease. 2013 Feb 5 . Edition 1. doi: 10.1371/currents.hd.ec3547da1c2a520ba959ee7bf8bdd202.

Reference

Chen JY, Wang E, Galvan L, Huynh M, Joshi P, Cepeda C, Levine MS. Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease. PLOS Currents Huntington Disease. 2013 Feb 5 . Edition 1. doi: 10.1371/currents.hd.ec3547da1c2a520ba959ee7bf8bdd202.